× Industry Reports Services Press Release Contact us About us

Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Share By Test Type (Fecal Occult Blood Tests [Guaiac FOB Stool, Immuno-FOB Agglutination, Lateral Flow Immuno-FOB, Immuno-FOB ELISA], Biomarker Tests [Tumor M2-PK Stool, Transferrin Assays], CRC DNA Screening Tests [Methylated Gene Testing, Panel DNA Tests]) Industry Analysis Report, Regional Outlook (Japan, China, India, Australia, South Korea, Malaysia, Indonesia, Thailand, Singapore, Taiwan, Philippines, Vietnam), Application Potential, Competitive Market Share & Forecast, 2020 - 2026

Published Date: February 2020 | Publisher: Graphical Research Report ID: GR1303 | Delivery : PDF

Report Content

Chapter 1.     Methodology

1.1.   Definition and forecast parameters

1.1.1.  Definitions

1.1.2.  Methodology and forecast parameters        

1.2.   Data sources 

1.3.   References & sources

1.3.1.  Secondary

1.3.2.  Primary

Chapter 2.     Executive Summary

2.1.   Asia Pacific in-vitro colorectal cancer screening tests industry summary, 2015 - 2026

2.1.1.  Country trends

2.1.2.  Test type trends

Chapter 3.     Industry Insights

3.1.   Industry segmentation

3.2.   Industry outlook, 2015 - 2026

3.3.   Major factor analysis

3.3.1.  Drivers

3.3.1.1.   Increasing incidence of CRC in the region

3.3.1.2.   Technological advancement in in-vitro colorectal cancer screening tests

3.3.1.3.   Favorable funding and rising government initiatives for early detection of CRC

3.3.2.  Restraints & challenges

3.3.2.1.   Lack of reimbursement in developing countries

3.4.   Regulatory landscape

3.4.1.  China

3.5.   Technology landscape

3.6.   Porter’s analysis

3.7.   Competitive review, 2019

3.8.   PEST analysis

Chapter 4.         Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Share, By Test Type

4.1.   Key trends in Asia Pacific in-vitro colorectal cancer screening tests, by test type

4.2.   Fecal occult blood test

4.2.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.2.2.  Guaiac FOB stool test

4.2.2.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.2.3.  Immuno-FOB agglutination test

4.2.3.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.2.4.  Lateral flow immuno-FOB test

4.2.4.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.2.5.  Immuno-FOB ELISA test

4.2.5.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.3.   Biomarker test

4.3.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.3.2.  Tumor M2-PK stool test

4.3.2.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.3.3.  Transferrin assays

4.3.3.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.4.   CRC DNA screening test

4.4.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.4.2.  Methylated gene test

4.4.2.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.4.3.  Panel DNA test

4.4.3.1.      Market estimates and forecast, by country, 2015 - 2026  (USD Million)

Chapter 5.         Asia Pacific In-vitro Colorectal Cancer Screening Tests Size, By Country

5.1.   Key trends in Asia Pacific in-vitro colorectal cancer screening tests, by country

5.2.   Japan

5.2.1.   Market estimates and forecast, by test type, 2015 - 2026  (USD Million)

5.3.   China

5.3.1.   Market estimates and forecast, by test type, 2015 - 2026 (USD Million)

5.4.   India

5.4.1.   Market estimates and forecast, by test type, 2015 - 2026 (USD Million)

5.5.   Australia

5.5.1.   Market estimates and forecast, by test type, 2015 - 2026 (USD Million)

5.6.   South Korea

5.6.1.   Market estimates and forecast, by test type, 2015 - 2026 (USD Million)

5.7.   Malaysia

5.7.1.   Market estimates and forecast, by test type, 2015 - 2026 (USD Million)

5.8.   Indonesia

5.8.1.   Market estimates and forecast, by test type, 2015 - 2026 (USD Million)

5.9.   Thailand

5.9.1.   Market estimates and forecast, by test type, 2015 - 2026 (USD Million)

5.10.   Singapore

5.10.1. Market estimates and forecast, by test type, 2015 - 2026 (USD Million)

5.11.   Taiwan

5.11.1. Market estimates and forecast, by test type, 2015 - 2026 (USD Million)

5.12.   Philippines

5.12.1. Market estimates and forecast, by test type, 2015 - 2026 (USD Million)

5.13.   Vietnam

5.13.1. Market estimates and forecast, by test type, 2015 - 2026 (USD Million)

Chapter 6.     Company Profiles

6.1.   Abbott Laboratories 

6.1.1.  Business overview

6.1.2.  Financial data

6.1.3.  Product landscape

6.1.4.  Strategic outlook

6.2.   Beckman Coulter, Inc.

6.2.1.  Business overview

6.2.2.  Financial data

6.2.3.  Product landscape

6.2.4.  Strategic outlook

6.3.   Eiken Chemical Co. Ltd. 

6.3.1.  Business overview

6.3.2.  Financial data

6.3.3.  Product landscape

6.3.4.  Strategic outlook

6.4.   EMD Millipore (Merck Group)

6.4.1.  Business overview

6.4.2.  Financial data

6.4.3.  Product landscape

6.4.4.  Strategic outlook

6.5.   Kyowa Kirin Co., Ltd. (Kyowa Medex Co., Ltd.)

6.5.1.  Business overview

6.5.2.  Financial data

6.5.3.  Product landscape

6.5.4.  Strategic outlook

6.6.   Randox Laboratories Ltd.

6.6.1.   Business overview

6.6.2.   Financial data

6.6.3.   Product landscape

6.6.4.   Strategic outlook

6.7.   R-Biopharm AG

6.7.1.   Business overview

6.7.2.   Financial data

6.7.3.   Product landscape

6.7.4.   Strategic outlook

6.8.   Roche Molecular System, Inc.

6.8.1.   Business overview

6.8.2.   Financial data

6.8.3.   Product landscape

6.8.4.   Strategic outlook

6.9.   Siemens Healthcare

6.9.1.   Business overview

6.9.2.   Financial data

6.9.3.   Product landscape

6.9.4.   Strategic outlook

6.10. Sysmex Corporation

6.10.1. Business overview

6.10.2. Financial data

6.10.3. Product landscape

6.10.4. Strategic outlook

Data Tables

TABLE 1.    Asia Pacific market estimates by country, (USD Mn), 2015 - 2019

TABLE 2.    Asia Pacific market forecast by country, (USD Mn), 2020 - 2026

TABLE 3.    Asia Pacific market estimates by test type, (USD Mn), 2015 - 2019

TABLE 4.    Asia Pacific market forecast by test type, (USD Mn), 2020 – 2026

TABLE 5.    Guideline for various patient group

TABLE 6.    Asia Pacific fecal occult blood test market estimates and forecast, by country, 2015 – 2026 (USD Mn)

TABLE 7.    Asia Pacific guaiac FOB stool test market estimates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 8.    Asia Pacific immuno-FOB agglutination test market estimates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 9.    Asia Pacific lateral flow immuno-FOB test market estimates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 10.  Asia Pacific immuno-FOB ELISA test market estimates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 11.  Asia Pacific biomarker test market estimates and forecast, by country, 2015 – 2026 (USD Mn)

TABLE 12.  Asia Pacific tumor M2-PK stool test market estimates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 13.  Asia Pacific transferrin assays market estimates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 14.  Asia Pacific CRC DNA screening test market estimates and forecast, by country, 2014 – 2026 (USD Mn)

TABLE 15.  Asia Pacific methylated gene test market estimates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 16.  Asia Pacific panel DNA test market estimates and forecast, by country, 2015 - 2026 (USD Mn)

TABLE 17.  Asia Pacific in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 18.  Asia Pacific in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 19.  Asia Pacific in-vitro colorectal cancer screening tests market estimates, by country (USD Mn), 2015 - 2019

TABLE 20.  Asia Pacific in-vitro colorectal cancer screening tests market forecast, by country (USD Mn), 2020 - 2026

TABLE 21.  Asia Pacific in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 22.  Asia Pacific in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 23.  Asia Pacific in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 24.  Asia Pacific in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 25.  Asia Pacific in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 26.  Asia Pacific in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 - 2026

TABLE 27.  Japan in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 28.  Japan in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 29.  Japan in-vitro colorectal cancer screening tests estimates, by test type, (USD Mn), 2015 - 2019

TABLE 30.  Japan in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 31.  Japan in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 32.  Japan in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 33.  Japan in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 34.  Japan in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 35.  Japan in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 36.  Japan in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 - 2026

TABLE 37.  China in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 38.  China in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 39.  China in-vitro colorectal cancer screening tests market estimates, by test type, (USD Mn), 2015 - 2019

TABLE 40.  China in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 41.  China in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 42.  China in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 43.  China in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 44.  China in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 45.  China in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 46.  China in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 – 2026

TABLE 47.  India in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 48.  India in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 49.  India in-vitro colorectal cancer screening tests estimates, by test type, (USD Mn), 2015 - 2019

TABLE 50.  India in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 51.  India in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 52.  India in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 53.  India in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 54.  India in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 55.  India in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 56.  India in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 - 2026

TABLE 57.  Australia in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 58.  Australia in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 59.  Australia in-vitro colorectal cancer screening tests estimates, by test type, (USD Mn), 2015 - 2019

TABLE 60.  Australia in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 61.  Australia in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 62.  Australia in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 63.  Australia in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 64.  Australia in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 65.  Australia in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 66.  Australia in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 - 2026

TABLE 67.  South Korea in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 68.  South Korea in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 69.  South Korea in-vitro colorectal cancer screening tests market estimates, by test type, (USD Mn), 2015 - 2019

TABLE 70.  South Korea in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 71.  South Korea in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 72.  South Korea in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 73.  South Korea in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 74.  South Korea in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 75.  South Korea in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 76.  South Korea in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 – 2026

TABLE 77.  Malaysia in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 78.  Malaysia in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 79.  Malaysia in-vitro colorectal cancer screening tests estimates, by test type, (USD Mn), 2015 - 2019

TABLE 80.  Malaysia in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 81.  Malaysia in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 82.  Malaysia in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 83.  Malaysia in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 84.  Malaysia in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 85.  Malaysia in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 86.  Malaysia in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 - 2026

TABLE 87.  Indonesia in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 88.  Indonesia in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 89.  Indonesia in-vitro colorectal cancer screening tests market estimates, by test type, (USD Mn), 2015 - 2019

TABLE 90.  Indonesia in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 91.  Indonesia in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 92.  Indonesia in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 93.  Indonesia in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 94.  Indonesia in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 95.  Indonesia in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 96.  Indonesia in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 – 2026

TABLE 97.  Thailand in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 98.  Thailand in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 99.  Thailand in-vitro colorectal cancer screening tests estimates, by test type, (USD Mn), 2015 - 2019

TABLE 100.      Thailand in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 101.      Thailand in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 102.      Thailand in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 103.      Thailand in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 104.      Thailand in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 105.      Thailand in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 106.      Thailand in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 - 2026

TABLE 107.      Singapore in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 108.      Singapore in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 109.      Singapore in-vitro colorectal cancer screening tests estimates, by test type, (USD Mn), 2015 - 2019

TABLE 110.      Singapore in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 111.      Singapore in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 112.      Singapore in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 113.      Singapore in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 114.      Singapore in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 115.      Singapore in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 116.      Singapore in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 - 2026

TABLE 117.      Taiwan in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 118.      Taiwan in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 119.      Taiwan in-vitro colorectal cancer screening tests market estimates, by test type, (USD Mn), 2015 - 2019

TABLE 120.      Taiwan in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 121.      Taiwan in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 122.      Taiwan in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 123.      Taiwan in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 124.      Taiwan in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 125.      Taiwan in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 126.      Taiwan in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 – 2026

TABLE 127.      Philippines in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 128.      Philippines in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 129.      Philippines in-vitro colorectal cancer screening tests estimates, by test type, (USD Mn), 2015 - 2019

TABLE 130.      Philippines in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 131.      Philippines in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 132.      Philippines in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 133.      Philippines in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 134.      Philippines in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 135.      Philippines in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 136.      Philippines in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 – 2026

TABLE 137.      Vietnam in-vitro colorectal cancer screening tests market estimates, (USD Mn), 2015 - 2019

TABLE 138.      Vietnam in-vitro colorectal cancer screening tests market forecast, (USD Mn), 2020 - 2026

TABLE 139.      Vietnam in-vitro colorectal cancer screening tests market estimates, by test type, (USD Mn), 2015 - 2019

TABLE 140.      Vietnam in-vitro colorectal cancer screening tests market forecast, by test type, (USD Mn), 2020 – 2026

TABLE 141.      Vietnam in-vitro colorectal cancer screening tests, by FOBT market estimates, (USD Mn), 2015 - 2019

TABLE 142.      Vietnam in-vitro colorectal cancer screening tests, by FOBT market forecast, (USD Mn), 2020 - 2026

TABLE 143.      Vietnam in-vitro colorectal cancer screening tests, by biomarker test market estimates, (USD Mn), 2015 - 2019

TABLE 144.      Vietnam in-vitro colorectal cancer screening tests, by biomarker test market forecast, (USD Mn), 2020 - 2026

TABLE 145.      Vietnam in-vitro colorectal cancer screening tests, by CRC DNA screening market estimates, (USD Mn), 2015 - 2019

TABLE 146.      Vietnam in-vitro colorectal cancer screening tests, by CRC DNA screening market forecast, (USD Mn), 2020 – 2026

Charts & Figures

FIG 1.     Industry segmentation

FIG 2.     Asia Pacific in-vitro colorectal cancer screening tests industry outlook, 2015 - 2026

FIG 3.     Porter’s analysis

FIG 4.     PEST analysis


Select License

APAC In-vitro Colorectal Cancer Screening Tests Market Forecast (2020-2026)


Related Reports
Why Choose us?
  • On-Time Delivery - logo On-Time Delivery
  • Assured Quality - logo Assured Quality
  • Industry Experts - logo Industry Experts
  • Payment Security - logo Payment Security
Share Social-media